UHC Expands Neurostim Coverage

Effective March 2022, United Healthcare will expand indications for implanted electrical spinal cord stimulators.

This change comes after IPSIS and 11 other medical society members of the Multisociety Pain Workgroup (MPW) submitted a comment letter to UHC urging the insurer to revise their policy.

The expanded spinal cord stimulator coverage indications will include complex regional pain syndrome (CRPS), diabetic neuropathy, and failed back surgery syndrome. The policy also outlines changes to include coverage of dorsal root ganglion stimulation for treating refractory CRPS I and CRPS II. Read the full policy here.

Help sustain this vital advocacy with your donations. The International Pain and Spine Intervention Society (IPSIS) is a tax exempt organization under US section 501(c)(3) of the Internal Revenue Code. As such, contributions are deductible to the extent allowed by law.